White Matter Free Water Biomarker for Alzheimer’s Disease
Dr. Maxime Descoteaux, Co-founder and CSO of Imeka, “the only company to combine diffusion and AI to map white matter integrity” discusses the use of white matter free water biomarker in Alzheimer’s disease and why scientists should change their focus from grey matter to white matter when it comes to evaluating Alzheimer’s disease. He also comments on MRI’s analyzed from INmune Bio’s XPro1595Phase 1b Clinical Trial.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Alzheimer. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Alzheimer and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Alzheimer?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Key Takeaways
- Key Point: Maxime Descoteaux, Co-founder and CSO of Imeka, “the only company to combine diffusion and AI to map white matter integrity” discusses the use of white matter free water biomark…
- Key Point: is Co-Founder & Chief Scientific Officer of Imeka.
- Key Point: from the INRIA Sophia-Antipolis and a post-doctorate fellow at the NeuroSpin, CEA Saclay in Paris, in computer sciences and neuroimaging, Maxime is an international leader in me…
- Key Point: Among other things, Maxime leads the SCIL (Sherbrooke connectivity imaging lab), a lab known for its integrated approach to diffusion MRI.
- Key Point: Descoteaux has more than 73 authored papers, 8 prizes, and in 2018 he was the chair of the best international medical image computing conference (MICCAI).
Maxime Descoteaux, Ph.D. is Co-Founder & Chief Scientific Officer of Imeka. With a Ph.D. from the INRIA Sophia-Antipolis and a post-doctorate fellow at the NeuroSpin, CEA Saclay in Paris, in computer sciences and neuroimaging, Maxime is an international leader in medical imaging and diffusion MRI, acquisition, reconstruction, visualization and processing in many clinical applications. Among other things, Maxime leads the SCIL (Sherbrooke connectivity imaging lab), a lab known for its integrated approach to diffusion MRI. Dr. Descoteaux has more than 73 authored papers, 8 prizes, and in 2018 he was the chair of the best international medical image computing conference (MICCAI). Besides being the CSO of Imeka, Dr. Maxime currently also serves as Assistant Professor of Computer Science at the University of Sherbrooke, Canada.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.



